Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
PGNY
|
David J Schlanger
Executive Chairman |
SELL
Open market or private sale
|
Indirect | 40,000 Reduced 9.38% |
$1,410,400
$35.26 p/Share
|
Dec 01
2020 |
|
PGNY
|
Peter Anevski
CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Indirect | 21,000 Reduced 4.23% |
$740,460
$35.26 p/Share
|
Dec 01
2020 |
|
FWRD
|
Chris C Ruble
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 2,621 Reduced 8.2% |
$194,295
$74.13 p/Share
|
Dec 01
2020 |
|
SONO
|
Patrick Spence
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 27,023 Reduced 17.36% |
$599,640
$22.19 p/Share
|
Dec 01
2020 |
|
GKOS
|
William J Phd Link
Director |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 76.41% |
$3,417,000
$68.34 p/Share
|
Dec 01
2020 |
|
MGPI
|
Karen Seaberg |
SELL
Open market or private sale
|
Indirect | 10,000 Reduced 2.25% |
$435,800
$43.58 p/Share
|
Dec 01
2020 |
|
CBZ
|
Benaree Pratt Wiley
Director |
SELL
Open market or private sale
|
Direct | 700 Reduced 8.47% |
$17,136
$24.48 p/Share
|
Dec 01
2020 |
|
SSTK
|
Jonathan Oringer
EXECUTIVE CHAIRMAN |
SELL
Open market or private sale
|
Direct | 85,000 Reduced 0.62% |
$6,039,250
$71.05 p/Share
|
Dec 01
2020 |
|
YELP
|
Jeremy Stoppelman
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 400,000 Reduced 75.74% |
$12,924,001
$32.31 p/Share
|
Dec 01
2020 |
|
SDGR
|
Jennifer Daniel
EVP & Chief HR Officer |
SELL
Open market or private sale
|
Direct | 11,955 Reduced 64.13% |
$829,318
$69.37 p/Share
|
Dec 01
2020 |
|
SHAK
|
Daniel Harris Meyer
Director |
SELL
Open market or private sale
|
Indirect | 125,000 Reduced 4.75% |
$10,178,750
$81.43 p/Share
|
Dec 01
2020 |
|
MYRG
|
William A Koertner |
SELL
Open market or private sale
|
Direct | 16,697 Reduced 8.2% |
$863,068
$51.69 p/Share
|
Dec 01
2020 |
|
CODI
|
Anholt Investments Ltd.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 32,036 Reduced 0.38% |
$625,983
$19.54 p/Share
|
Dec 01
2020 |
|
SILK
|
Andrew S. Davis
Chief Commercial Officer |
SELL
Open market or private sale
|
Direct | 7,472 Reduced 27.4% |
$423,139
$56.63 p/Share
|
Dec 01
2020 |
|
ESTA
|
Santos Salvador Dada
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 300 Reduced 0.2% |
$8,106
$27.02 p/Share
|
Dec 01
2020 |
|
ZNTL
|
Kevin D. Bunker
Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect | 8,420 Reduced 1.88% |
$441,292
$52.41 p/Share
|
Dec 01
2020 |
|
KALU
|
Keith Harvey
President & CEO |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 1.4% |
$82,000
$82.0 p/Share
|
Dec 01
2020 |
|
CASH
|
Michael Robert Kramer
Director |
SELL
Open market or private sale
|
Indirect | 10,000 Reduced 29.28% |
$340,200
$34.02 p/Share
|
Dec 01
2020 |
|
UCTT
|
Clarence L Granger
Interim CEO |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 9.59% |
$480,000
$32.0 p/Share
|
Dec 01
2020 |
|
MGNI
|
Adam Lee Soroca
CHIEF PRODUCT OFFICER |
SELL
Open market or private sale
|
Direct | 10,365 Reduced 2.82% |
$201,807
$19.47 p/Share
|
Dec 01
2020 |
|
LMND
|
Daniel A. Schreiber
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 56,650 Reduced 7.32% |
$3,766,092
$66.48 p/Share
|
Dec 01
2020 |
|
LMND
|
Timothy E Bixby
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 20,100 Reduced 6.28% |
$1,337,253
$66.53 p/Share
|
Dec 01
2020 |
|
LMND
|
John Sheldon Peters
Chief Insurance Officer |
SELL
Open market or private sale
|
Direct | 28,800 Reduced 19.65% |
$1,914,624
$66.48 p/Share
|
Dec 01
2020 |
|
PLAB
|
Christopher J Progler
EVP, Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 8,340 Reduced 6.83% |
$98,245
$11.78 p/Share
|
Dec 01
2020 |
|
TNC
|
Chris Killingstad
Director |
SELL
Open market or private sale
|
Direct | 6,592 Reduced 4.22% |
$446,806
$67.78 p/Share
|
Dec 01
2020 |
|
ARQT
|
Howard G. Welgus
Director |
SELL
Open market or private sale
|
Direct | 2,200 Reduced 1.21% |
$57,816
$26.28 p/Share
|
Dec 01
2020 |
|
SSP
|
Mark L Koors
VP/Audit and Compliance |
SELL
Open market or private sale
|
Direct | 11,452 Reduced 22.78% |
$148,876
$13.0 p/Share
|
Dec 01
2020 |
|
SNDX
|
Michael A Metzger
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 45.93% |
$344,550
$22.97 p/Share
|
Dec 01
2020 |
|
MORF
|
Praveen P. Tipirneni
President and CEO |
SELL
Open market or private sale
|
Indirect | 4,000 Reduced 0.62% |
$124,960
$31.24 p/Share
|
Dec 01
2020 |
|
MORF
|
Praveen P. Tipirneni
President and CEO |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 51.2% |
$124,960
$31.24 p/Share
|
Dec 01
2020 |
|
HCAT
|
Paul Horstmeier
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 10,750 Reduced 11.68% |
$380,765
$35.42 p/Share
|
Dec 01
2020 |
|
HCAT
|
James Patrick Nelli Jr.
President |
SELL
Open market or private sale
|
Direct | 33,582 Reduced 27.79% |
$1,188,803
$35.4 p/Share
|
Dec 01
2020 |
|
HCAT
|
Daniel D. Burton
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 4,482 Reduced 2.12% |
$156,780
$34.98 p/Share
|
Dec 01
2020 |
|
HCAT
|
Daniel H. Orenstein
General Counsel |
SELL
Open market or private sale
|
Direct | 6,084 Reduced 15.21% |
$212,757
$34.97 p/Share
|
Dec 01
2020 |
|
HCAT
|
Linda Llewelyn
Chief People Officer |
SELL
Open market or private sale
|
Direct | 1,570 Reduced 6.19% |
$54,934
$34.99 p/Share
|
Dec 01
2020 |
|
DCPH
|
Michael Douglas Taylor
Director |
SELL
Open market or private sale
|
Direct | 19,000 Reduced 100.0% |
$1,169,450
$61.55 p/Share
|
Dec 01
2020 |
|
ATEX
|
Elaine Gangeri
Chief Acc Officer, Treasurer |
SELL
Open market or private sale
|
Direct | 1,018 Reduced 3.6% |
$30,642
$30.1 p/Share
|
Dec 01
2020 |
|
QTRX
|
Mark T. Roskey
SVP, Strategic Partnerships |
SELL
Open market or private sale
|
Direct | 91 Reduced 0.41% |
$3,979
$43.72 p/Share
|
Dec 01
2020 |
|
QTRX
|
Dawn Mattoon
Sr. VP, Diagnostics |
SELL
Open market or private sale
|
Direct | 158 Reduced 0.5% |
$6,908
$43.72 p/Share
|
Dec 01
2020 |
|
QTRX
|
Amol Chaubal
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 115 Reduced 0.45% |
$5,028
$43.72 p/Share
|
Dec 01
2020 |
|
QTRX
|
John J Fry
General Counsel & Secretary |
SELL
Open market or private sale
|
Direct | 141 Reduced 0.44% |
$6,165
$43.72 p/Share
|
Dec 01
2020 |
|
QTRX
|
E Kevin Hrusovsky
Executive Chairman |
SELL
Open market or private sale
|
Direct | 3,236 Reduced 0.32% |
$141,478
$43.72 p/Share
|
Dec 01
2020 |
|
BLFS
|
Aby J. Mathew
EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 380 Reduced 0.21% |
$13,486
$35.49 p/Share
|
Dec 01
2020 |
|
BLFS
|
Karen A. Foster
Chief Quality and Operations |
SELL
Open market or private sale
|
Direct | 166 Reduced 0.33% |
$5,891
$35.49 p/Share
|
Dec 01
2020 |
|
BLFS
|
Michael Rice |
SELL
Open market or private sale
|
Direct | 813 Reduced 0.4% |
$28,853
$35.49 p/Share
|
Dec 01
2020 |
|
CSTL
|
Bernhard E. Spiess
Chief Business Officer |
SELL
Open market or private sale
|
Direct | 40,000 Reduced 77.3% |
$1,998,800
$49.97 p/Share
|
Dec 01
2020 |
|
QNST
|
Douglas Valenti
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 2,083 Reduced 0.53% |
$37,702
$18.1 p/Share
|
Dec 01
2020 |
|
BCYC
|
Lee Kalowski
President and CFO |
SELL
Open market or private sale
|
Direct | 7,500 Reduced 100.0% |
$168,750
$22.5 p/Share
|
Dec 01
2020 |
|
MBWM
|
Robert T. Worthington
SVP, CRO, SECRETARY, AND GC |
SELL
Open market or private sale
|
Direct | 3,500 Reduced 28.35% |
$87,640
$25.04 p/Share
|
Dec 01
2020 |
|
STOK
|
Huw M. Nash
Chief Business Officer |
SELL
Open market or private sale
|
Direct | 5,700 Reduced 100.0% |
$289,845
$50.85 p/Share
|
Dec 01
2020 |